SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-015928
Filing Date
2022-06-27
Accepted
2022-06-27 07:00:40
Documents
13
Period of Report
2022-06-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K rvph20220624_8k.htm   iXBRL 8-K 25414
  Complete submission text file 0001437749-22-015928.txt   177230

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rvph-20220623.xsd EX-101.SCH 4057
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvph-20220623_def.xml EX-101.DEF 13923
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvph-20220623_lab.xml EX-101.LAB 18268
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvph-20220623_pre.xml EX-101.PRE 13945
7 EXTRACTED XBRL INSTANCE DOCUMENT rvph20220624_8k_htm.xml XML 4459
Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38634 | Film No.: 221041569
SIC: 2834 Pharmaceutical Preparations